[Abstract Only] Overall Survival with Ribociclib plus Endocrine Therapy in Breast Cancer
5 Aug, 2019 | 01:49h | UTCOverall Survival with Ribociclib plus Endocrine Therapy in Breast Cancer – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary: Overall Survival With the Addition of Ribociclib to Endocrine Therapy in Advanced HR-Positive, HER2-Negative Breast Cancer – The ASCO Post (free)